These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 5849261)

  • 21. Drug product equivalence--the problem, the challenge, and the U.S.P.
    Macek TJ
    Am J Pharm Sci Support Public Health; 1971; 143(6):188-94. PubMed ID: 5140167
    [No Abstract]   [Full Text] [Related]  

  • 22. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 23. Background for U.S.P., N.F. and N.D. Medicare requirement.
    Heller WM
    Am J Hosp Pharm; 1966 Jun; 23(6):320-1. PubMed ID: 5943312
    [No Abstract]   [Full Text] [Related]  

  • 24. Standardization of forensic drug analyses.
    Frank RS; Gunn JW
    J Forensic Sci; 1974 Jan; 19(1):163-7. PubMed ID: 4854386
    [No Abstract]   [Full Text] [Related]  

  • 25. Product dissolution methods: response.
    Tingstad JE
    J Pharm Sci; 1973 Jul; 62(7):VI. PubMed ID: 4714144
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pharmacopeia and preparations for cutaneous application].
    Esnault F; Etchegaray JP; Mallard C
    Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S40-5. PubMed ID: 17563714
    [No Abstract]   [Full Text] [Related]  

  • 27. Evolution of a children's drug table.
    Shirkey HC
    Hosp Formul; 1979 Mar; 14(3):319-20, 325-6, 330. PubMed ID: 10316796
    [No Abstract]   [Full Text] [Related]  

  • 28. The Food and Drug Administration and its position in regard to new dental and oral drugs.
    Gilkes CC
    J Colo Dent Assoc; 1973 Nov; 52(2):27-30. PubMed ID: 4521169
    [No Abstract]   [Full Text] [Related]  

  • 29. COMMENTARY: AIDS TO WISE CHOICE AMONG NEW DRUG PRODUCTS MARKETED IN THE UNITED STATES.
    MAY CD
    Clin Pharmacol Ther; 1964; 5():7-11. PubMed ID: 14107124
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug product quality--views of the regulators. USP/NF: public standards for drug product quality.
    Grady LT
    J Am Pharm Assoc; 1976 Nov; 16(11):603-4. PubMed ID: 977885
    [No Abstract]   [Full Text] [Related]  

  • 31. Report on the PQRI impurity characterization and quantification best practices survey.
    Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF
    Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396
    [No Abstract]   [Full Text] [Related]  

  • 32. The new USP-NF: drug standards and patient information.
    Heller WM
    Hosp Formul; 1980 Jan; 15(1):21-4. PubMed ID: 10244954
    [No Abstract]   [Full Text] [Related]  

  • 33. University-industry relationships in dentistry: past, present, future.
    Barnett ML
    J Dent Educ; 2002 Oct; 66(10):1163-8. PubMed ID: 12449211
    [No Abstract]   [Full Text] [Related]  

  • 34. Retrospective view of the interfacial relationship of the pharmaceutical industry with the Food and Drug Administration and the United States Pharmacopeia.
    Hammer HF
    J Parenter Sci Technol; 1984; 38(4):159-63. PubMed ID: 6491859
    [No Abstract]   [Full Text] [Related]  

  • 35. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
    [No Abstract]   [Full Text] [Related]  

  • 36. [The new drug formulary (NDF) of the German drug codex].
    Reimann H
    Pharm Unserer Zeit; 2010 Jul; 39(4):274-9. PubMed ID: 20589798
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug standards--communication and revision.
    Barnstein CH
    J Parenter Drug Assoc; 1979; 33(5):237-8. PubMed ID: 259643
    [No Abstract]   [Full Text] [Related]  

  • 38. Official USP Reference Standards: metrology concepts, overview, and scientific issues and opportunities.
    Williams RL; ;
    J Pharm Biomed Anal; 2006 Jan; 40(1):3-15. PubMed ID: 16303277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the compendia in controlling factors affecting bioavailability of drug products.
    Blake MI
    J Am Pharm Assoc; 1971 Nov; 11(11):603-11. PubMed ID: 5133104
    [No Abstract]   [Full Text] [Related]  

  • 40. Setting standards: what the ADA does for dental alloys.
    Somer C
    Dent Lab Manage Today; 1985; 1(9):8, 11, 13. PubMed ID: 3861924
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.